Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil R Hackett

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
Four decades of adenovirus gene transfer vectors: History and current useNeil R Hackett, Ronald G Crystal
BMC Molecular Biology|November 20, 2009
Identification of an exonic splicing silencer in exon 6A of the human VEGF geneRui Wang, Ronald G Crystal, Neil R Hackett
Circulation Research|July 30, 2005
Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemiaHideki Amano, Neil R Hackett, Shahin Rafii, et al.
Human Gene Therapy|November 25, 2003
Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigenYadi Tan, Neil R Hackett, Julie L Boyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAVBishnu P De, Neil R Hackett, Ronald G Crystal, et al.
Human Gene Therapy|March 29, 2012
Double-blinded, placebo-controlled, randomized gene therapy using surgery for vector deliveryRonald G Crystal, Stephen M Kaminsky, Neil R Hackett, et al.
Human Gene Therapy|March 8, 2008
Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient miceMasaki Watanabe, Julie L Boyer, Neil R Hackett, et al.
Journal of Virology|October 19, 2007
Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprFStefan Worgall, Anja Krause, JianPing Qiu, et al.
Infection and Immunity|September 24, 2005
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunityMasahiko Hashimoto, Julie L Boyer, Neil R Hackett, et al.
Molecular Medicine (Cambridge, Mass.)|June 23, 2004
Sampling-dependent up-regulation of gene expression in sequential samples of human airway epithelial cellsAdriana Heguy, Ben-Gary Harvey, Timothy P O'Connor, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
Four decades of adenovirus gene transfer vectors: History and current useNeil R Hackett, Ronald G Crystal
BMC Molecular Biology|November 20, 2009
Identification of an exonic splicing silencer in exon 6A of the human VEGF geneRui Wang, Ronald G Crystal, Neil R Hackett
Circulation Research|July 30, 2005
Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemiaHideki Amano, Neil R Hackett, Shahin Rafii, et al.
Human Gene Therapy|November 25, 2003
Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigenYadi Tan, Neil R Hackett, Julie L Boyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAVBishnu P De, Neil R Hackett, Ronald G Crystal, et al.
Human Gene Therapy|March 29, 2012
Double-blinded, placebo-controlled, randomized gene therapy using surgery for vector deliveryRonald G Crystal, Stephen M Kaminsky, Neil R Hackett, et al.
Human Gene Therapy|March 8, 2008
Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient miceMasaki Watanabe, Julie L Boyer, Neil R Hackett, et al.
Journal of Virology|October 19, 2007
Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprFStefan Worgall, Anja Krause, JianPing Qiu, et al.
Infection and Immunity|September 24, 2005
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunityMasahiko Hashimoto, Julie L Boyer, Neil R Hackett, et al.
Molecular Medicine (Cambridge, Mass.)|June 23, 2004
Sampling-dependent up-regulation of gene expression in sequential samples of human airway epithelial cellsAdriana Heguy, Ben-Gary Harvey, Timothy P O'Connor, et al.
Pageof 9